Turnover of adenosine in plasma of human and dog blood
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
To determine half-life and turnover of plasma adenosine, heparinized blood from healthy volunteers was incubated with radiolabeled adenosine in the physiological concentration range of 0.1-1 microM. Plasma levels of adenosine in vitro were 82 +/- 14 nM and were similar to those determined immediately after blood collection with a "stopping solution." Dipyridamole (83 microM) and erythro-9(2-hydroxynon-3yl)-adenine (EHNA) (8 microM) did not measurably alter basal adenosine levels but completely blocked the uptake of added adenosine. Inhibition of ecto-5'-nucleotidase with 100 microM alpha, beta-methyleneadenosine 5'-diphosphate (AOPCP) reduced plasma adenosine to 22 +/- 6 nM. For the determination of adenosine turnover, the decrease in specific radioactivity of added [3H]adenosine was measured using a dipyridamole-containing stopping solution. Without altering basal adenosine levels, the half-life was estimated to be 0.6 s. Similar experiments were carried out with washed erythrocytes or in the presence of AOPCP, yielding half-lives of 0.7 and 0.9 s, respectively. When the initial adenosine concentration was 1 microM, its specific activity decreased by only 11% within 5 s, whereas total plasma adenosine exponentially decreased with a half-life of 1.5 s. Venous plasma concentrations were measured after relief of a 3-min forearm ischemia. Changes in plasma adenosine did not correlate well with changes in blood flow but were augmented in the presence of dipyridamole.(ABSTRACT TRUNCATED AT 250 WORDS)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pearson, J. D., Carleton, J. S., & Gordon, J. L. (1980) · Biochemical Journal · doi:10.1042/bj1900421 · Cited by 333
Dipyridamole inhibition of adenosine metabolism in human blood
Klabunde, R. E. (1983) · European Journal of Pharmacology · doi:10.1016/0014-2999(83)90026-2 · Cited by 263
Cardiovascular effects of adenosine in man; possible clinical implications
Sollevi, A. (1986) · Progress in Neurobiology · doi:10.1016/0301-0082(86)90005-5 · Cited by 222
Supply-to-demand ratio for oxygen determines formation of adenosine by the heart
Bardenheuer, H., & Schrader, J. (1986) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1986.250.2.h173 · Cited by 167
Self-citationMeasurement of adenosine, inosine, and hypoxanthine in human plasma
Ontyd, J., & Schrader, J. (1984) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)84113-4 · Cited by 145
Self-citationRelease of Adenosine from Human Hearts during Angina Induced by Rapid Atrial Pacing
Fox, A. C., Reed, G. E., Glassman, E., Kaltman, A. J., & Silk, B. B. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107693 · Cited by 141
Contribution of coronary endothelial cells to cardiac adenosine production
Deußen, A., M�ser, G., & Schrader, J. (1986) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf00584028 · Cited by 123
Self-citationRole of S-adenosylhomocysteine hydrolase in adenosine metabolism in mammalian heart
Schrader, J., Schütz, W., & Bardenheuer, H. J. (1981) · Biochemical Journal · doi:10.1042/bj1960065 · Cited by 112
Self-citationFormation of S-adenosylhomocysteine in the heart. I: An index of free intracellular adenosine.
Deußen, A., Borst, M. M., & Schrader, J. (1988) · Circulation Research · doi:10.1161/01.res.63.1.240 · Cited by 91
Self-citationBardenheuer, H. J., & Schrader, J. (1983) · Circulation Research · doi:10.1161/01.res.52.3.263 · Cited by 81
Self-citation
Cited by
Nomenclature and classification of purinoceptors.
Fredholm, B. B., Abbracchio, M. P., Burnstock, G., Daly, J. W., Harden, T. K., Jacobson, K. A., Leff, P., & Williams, M. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06782-1 · Cited by 1,585
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
Haskó, G., Linden, J., Cronstein, B., & Pacher, P. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2638 · Cited by 1,217
Adenosine, an endogenous anti-inflammatory agent
Cronstein, B. N. (1994) · Journal of Applied Physiology · doi:10.1152/jappl.1994.76.1.5 · Cited by 633
The adenosine pathway in immuno-oncology
Allard, B., Allard, D., Buisseret, L., & Stagg, J. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0382-2 · Cited by 586
Shryock, J. C., & Belardinelli, L. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00256-7 · Cited by 576
Hersh, A. M., Alomari, S., & Tyler, B. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084153 · Cited by 478
“However, its short circulation time renders it ineffective at crossing the BBB [71].”
BackgroundAdenosine receptor activation and nociception
Sawynok, J. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01605-1 · Cited by 472
Feoktistov, I., & Biaggioni, I. (1997) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01339-5 · Cited by 421
Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers
Brown, P. M., Pratt, A. G., & Isaacs, J. D. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.175 · Cited by 382
Cardiac electrophysiology of adenosine. Basic and clinical concepts.
Lerman, B. B., & Belardinelli, L. (1991) · Circulation · doi:10.1161/01.cir.83.5.1499 · Cited by 377
Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer
Fong, L., Hotson, A., Powderly, J. D., Sznol, M., Heist, R. S., Choueiri, T. K., George, S., Hughes, B. G. M., Hellmann, M. D., Shepard, D. R., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0980 · Cited by 352
Role of red blood cells in thrombosis
Andrews, D. A., & Low, P. S. (1999) · Current Opinion in Hematology · doi:10.1097/00062752-199903000-00004 · Cited by 349
Adenosine Metabolism: Emerging Concepts for Cancer Therapy
Boison, D., & Yegutkin, G. G. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.10.007 · Cited by 336
Cronstein, B. N., Eberle, M. A., Gruber, H. E., & Levin, R. I. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.6.2441 · Cited by 332
Adenosine-Mediated Effects of Ticagrelor
Cattaneo, M., Schulz, R., & Nylander, S. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.031 · Cited by 312
Adenosine in Bronchoalveolar Lavage Fluid in Asthma
Driver, A. G., Kukoly, C. A., Ali, S., & Mustafa, S. J. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/148.1.91 · Cited by 307
Adenosine and Supraventricular Tachycardia
Camm, A. J., & Garratt, C. J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112053252306 · Cited by 261
Squalenoyl adenosine nanoparticles provide neuroprotection after stroke and spinal cord injury
Gaudin, A., Yemisci, M., Eroglu, H., Lepetre-Mouelhi, S., Turkoglu, O. F., Dönmez-Demir, B., Caban, S., Sargon, M. F., Garcia-Argote, S., Pieters, G., et al. (2014) · Nature Nanotechnology · doi:10.1038/nnano.2014.274 · Cited by 261
Regulation of Neutrophil Function by Adenosine
Barletta, K. E., Ley, K., & Mehrad, B. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.226845 · Cited by 260
Koszalka, P., Özüyaman, B., Huo, Y., Zernecke, A., Flögel, U., Braun, N., Buchheiser, A., Decking, U. K. M., Smith, M. L., Sévigny, J., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000144796.82787.6f · Cited by 236
Self-citationWillingham, S. B., Ho, P. Y., Hotson, A., Hill, C., Piccione, E. C., Hsieh, J., Liu, L., Buggy, J. J., McCaffery, I., & Miller, R. A. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0056 · Cited by 222
“This method avoided the use of exogenous 555 adenosine catabolism inhibitors that block adenosine degradation and transport ( plasma t1/2 ≤ 10 556 sec) resulting in artificially elevated measurements by allowing adenosine to accumulate in the 557 sample (49).”
MethodHe, B., Hoang, T. K., Wang, T., Ferris, M., Taylor, C. M., Tian, X., Luo, M., Tran, D. Q., Zhou, J., Tatevian, N., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20160961 · Cited by 196
Inhibition of UBA6 by inosine augments tumour immunogenicity and responses
(2022) · doi:10.1038/s41467-022-33116-z · Cited by 82
The impact of caffeine on vasodilator stress perfusion studies
Lapeyre, A. C., Goraya, T. Y., Johnston, D. L., & Gibbons, R. J. (2004) · Journal of Nuclear Cardiology · doi:10.1016/j.nuclcard.2004.04.003 · Cited by 39
Koglin, J., Böhm, M., von Scheidt, W., Stäblein, A., & Erdmann, E. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90754-4 · Cited by 21
Metadata
- Authors
- Moser, G. H., Schrader, J., & Deussen, A.
- Venue
- American Journal of Physiology-Cell Physiology
- Publisher
- American Physiological Society
- Published
- 1989-04-01
- Volume
- 256
- Issue
- 4
- Pages
- C799-C806
- ISSN
- 0363-6143 (ISSN-L)
- 1522-1563
- OpenAlex
- W2336295169
- Cited by
- 529
- References
- 18
- FWCI
- 6.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.